If you're navigating MS care in Michigan, you have multiple centers across the state to consider, from Detroit-area hubs like Henry Ford Hospital and Wayne State University to regional programs such as Mercy Health Saint Mary's and Corewell Health. Use this overview to compare care models and locations so you can find the clinic that best matches your needs and preferences.
8 MS treatment centers25 active clinical trialsTop centers include Henry Ford Hospital and Mercy Health Saint Mary'sNo Medicare prescribing data available
Center types in Michigan
Dedicated MS Practice (4)
Community Hospital Program (2)
Regional Neurology Group (1)
Academic MS Center (1)
Filter by type:
50% of MS centers in Michigan are classified as Dedicated MS Practice facilities.
Centers with Most Active Trials in Michigan
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
MS Care by City
Active MS clinical trials in Michigan
See all 30 MS trials in Michigan →ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Farmington Hills
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Detroit · Owosso
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Detroit · Rochester Hills
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Detroit
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Detroit · Detroit
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Detroit
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Detroit




